| scholarly article | Q13442814 |
| P50 | author | Ulf Landmesser | Q27235435 |
| Manfred Claassen | Q91917016 | ||
| Gerhard Liebisch | Q42705098 | ||
| Sandra Goetze | Q42867772 | ||
| Alaa Othman | Q46712348 | ||
| Niko Beerenwinkel | Q47134273 | ||
| Gergely Karsai | Q64516138 | ||
| Monika Hunjadi | Q84965107 | ||
| Mustafa Yalçınkaya | Q87709739 | ||
| Johannes Jakob Hartung | Q89824380 | ||
| P2093 | author name string | Christian Wolfrum | |
| Thorsten Hornemann | |||
| Andreas Ritsch | |||
| Nicolle Kränkel | |||
| Arnold von Eckardstein | |||
| Bernd Wollscheid | |||
| Lucia Rohrer | |||
| Andrej Shemet | |||
| Miroslav Balaz | |||
| Jan Krützfeldt | |||
| Edlira Luca | |||
| Erick Carreira | |||
| Mathias Cardner | |||
| Michaela Keel | |||
| Silvija Radosavljevic | |||
| P2860 | cites work | High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk | Q26775420 |
| High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis | Q27021241 | ||
| GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex | Q28205232 | ||
| Analysis of lipoprotein-specific lipids in patients with acute coronary syndrome by asymmetrical flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry | Q91647391 | ||
| HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease | Q92311876 | ||
| Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence | Q92511123 | ||
| Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile | Q93017355 | ||
| Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity | Q93239671 | ||
| Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease | Q93334941 | ||
| Glycosylphosphatidylinositol-specific phospholipase D improves glucose tolerance | Q28585396 | ||
| Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism | Q28593575 | ||
| The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice | Q28594692 | ||
| Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F | Q28626790 | ||
| A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids | Q29547337 | ||
| Mendelian randomization in cardiometabolic disease: challenges in evaluating causality | Q30234302 | ||
| Sparse partial least squares regression for simultaneous dimension reduction and variable selection | Q33608112 | ||
| Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women | Q33803431 | ||
| High-density lipoprotein subclasses and their relationship to cardiovascular disease. | Q34322150 | ||
| Sparse inverse covariance estimation with the graphical lasso | Q34484010 | ||
| Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells | Q34624089 | ||
| Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects | Q34694879 | ||
| Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. | Q35051225 | ||
| Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy | Q35535621 | ||
| The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes | Q36062980 | ||
| Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis. | Q37606651 | ||
| Microdomains, Inflammation, and Atherosclerosis. | Q37623996 | ||
| High-density lipoprotein, beta cells, and diabetes . | Q38218039 | ||
| Signal transduction by HDL: agonists, receptors, and signaling cascades | Q38293447 | ||
| HDL cholesterol: reappraisal of its clinical relevance | Q38739884 | ||
| Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy | Q38773023 | ||
| Serum amyloid A and atherosclerosis | Q38826020 | ||
| Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. | Q38868098 | ||
| Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study | Q39056522 | ||
| Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c. | Q39213945 | ||
| Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes | Q39809960 | ||
| Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size | Q39888201 | ||
| Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. | Q39917023 | ||
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel | Q40227478 | ||
| Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. | Q40325621 | ||
| MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study | Q40682012 | ||
| Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels | Q40775220 | ||
| Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk | Q41507824 | ||
| HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium | Q41769236 | ||
| Free radical modulation of insulin release in INS-1 cells exposed to alloxan | Q42468349 | ||
| Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling | Q43630795 | ||
| Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance | Q44286392 | ||
| High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm | Q45136777 | ||
| Gas chromatography and mass spectrometry of sphingolipid bases. Characterization of sphinga-4,14-dienine from plasma sphingomyelin | Q45276207 | ||
| Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome | Q46610170 | ||
| Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL. | Q46712291 | ||
| Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles | Q46805800 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome | Q47172809 | ||
| Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure | Q47281852 | ||
| Trials and Tribulations of CETP Inhibitors | Q47669381 | ||
| Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine. | Q50260227 | ||
| Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample. | Q51695625 | ||
| Determinants of cholesterol efflux capacity in humans. | Q52740029 | ||
| A critical appraisal of the measurement of serum 'cholesterol efflux capacity' and its use as surrogate marker of risk of cardiovascular disease | Q57298447 | ||
| Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol | Q58129761 | ||
| Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls | Q61817281 | ||
| Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity | Q64236956 | ||
| Structure of plasma sphingadienine | Q71251029 | ||
| HDL and plasma phospholipids in coronary artery disease | Q72031758 | ||
| Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease | Q74315464 | ||
| Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein | Q85792912 | ||
| Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography | Q86978267 | ||
| ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters | Q90068241 | ||
| Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease | Q90808224 | ||
| From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants | Q91177628 | ||
| P433 | issue | 1 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P577 | publication date | 2020-01-16 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Structure-function relationships of HDL in diabetes and coronary heart disease | |
| P478 | volume | 5 |
Search more.